LOS ANGELES, Jan. 13, 2011 /PRNewswire/ — UBM Canon and IVD Technology are proud
to add a new webinar to its webcast series on The Fundamentals of
In Vitro Diagnostics. This one-hour event will focus
specifically on
Advanced Assay Technologies and Development Methods and will
offer an in-depth analysis and discussion from experts in the
industry.
(Logo: http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)
Various market reports and studies have concluded that the
future for immunoassays is a mixed bag. In the clinical laboratory,
mature assays will show moderate growth while emerging
assays will fuel most of the growth in this IVD segment.
However, all
immunoassays will have to pass the test of medical research to
demonstrate their contributions to improving patient outcomes. In
this webinar event, attendees will learn more about how
immunoassays, combined with DNA probe studies, will have an
important place in
post-genomic medicine.
This Webcast will feature presentations by Neal Siegel, PhD,
Chief Scientific Officer, Sword Diagnostics; Scott Dylewski, PhD,
Senior Scientist, Alverix Inc.; and Nick Gee, PhD, CEO/CSO, Innova
Biosciences Ltd. The Webcast concludes with a live Q&A session
moderated by Richard Park, Editor-in-Chief of IVD Technology
magazine. For more information on our speakers,
SOURCE